SKI Market

Indian Indices

Sensex

82,626.76 -1,048.16
( -1.25%)

Global Indices

Nasdaq

49,462.85 -679.56
(-1.36%)

Dow Jones

6,851.97 -110.50
(-1.59%)

Hang Seng

57,040.53 -599.31
(-1.04%)

Nikkei 225

10,413.72 -58.39
(-0.56%)

Forex

USD-INR

90.66 0.06
(0.07%)

EUR-INR

107.82 -0.02
(-0.02%)

GBP-INR

123.81 -0.01
(0.00%)

JPY-INR

0.59 0.01
(1.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

PTL Enterprises Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

509220

INE034D01049

45.3051285

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PTL

12.37

515.74

EPS(TTM)

Face Value()

Div & Yield %

3.15

4.49

Back

Vista Pharmaceuticals reports standalone net loss of Rs 2.59 crore in the September 2025 quarter

Nov 14,2025

Net Loss of Vista Pharmaceuticals reported to Rs 2.59 crore in the quarter ended September 2025 as against net loss of Rs 0.97 crore during the previous quarter ended September 2024. Sales declined 41.37% to Rs 1.46 crore in the quarter ended September 2025 as against Rs 2.49 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1.46	2.49	-41
OPM %	-234.93	-33.33	-
PBDT	-3.42	-1.07	-220
PBT	-3.62	-1.25	-190
NP	-2.59	-0.97	-167

82,626.76 -1,048.16 ( -1.25%)

49,462.85 -679.56 (-1.36%)

6,851.97 -110.50 (-1.59%)

57,040.53 -599.31 (-1.04%)

10,413.72 -58.39 (-0.56%)

90.66 0.06 (0.07%)

107.82 -0.02 (-0.02%)

123.81 -0.01 (0.00%)

0.59 0.01 (1.13%)